Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc.
Delobel
Pierre
P
Raymond
Stéphanie
S
Mavigner
Maud
M
Cazabat
Michelle
M
Alvarez
Muriel
M
Marchou
Bruno
B
Massip
Patrice
P
Izopet
Jacques
J
D000328:Adult; D003510:Cyclohexanes / Q000627:therapeutic use*; D024882:Drug Resistance, Viral / Q000235:genetics*; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D008297:Male; D000077592:Maraviroc; D010641:Phenotype; D014230:Triazoles / Q000627:therapeutic use*
D003510:Cyclohexanes; D023581:HIV Fusion Inhibitors; D014230:Triazoles; D000077592:Maraviroc